Multiple sclerosis and Nerve conduction studies abnormal

Summary:

Nerve conduction studies abnormal is found among people with Multiple sclerosis, especially for people who are female, 50-59 old.

The study analyzes which people have Nerve conduction studies abnormal with Multiple sclerosis. It is created by eHealthMe based on reports of 11 people who have Multiple sclerosis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Multiple sclerosis?

Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath) is found to be associated with 1,087 drugs and 1,362 conditions by eHealthMe. Check the latest studies of Multiple sclerosis.

What is Nerve conduction studies abnormal?

Nerve conduction studies abnormal is found to be associated with 43 drugs and 171 conditions by eHealthMe. Check the latest studies of Nerve conduction studies abnormal.



On Jul, 30, 2026

11 people who have Multiple Sclerosis and Nerve Conduction Studies Abnormal are studied.

Would you have Nerve conduction studies abnormal when you have Multiple sclerosis?

Gender of people who have Multiple Sclerosis and experienced Nerve Conduction Studies Abnormal *:

  • female: 90.91 %
  • male: 9.09 %

Age of people who have Multiple Sclerosis and experienced Nerve Conduction Studies Abnormal *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 55.56 %
  • 60+: 44.44 %

Common co-existing conditions for these people *:

  1. High Blood Pressure: 2 people, 18.18%
  2. Oesophageal Disorder (disease of oesophagus): 1 person, 9.09%
  3. Heart Rate Irregular: 1 person, 9.09%

Common drugs taken by these people *:

  1. Plegridy: 5 people, 45.45%
  2. Avonex: 3 people, 27.27%
  3. Tysabri: 2 people, 18.18%
  4. Fish Oil: 2 people, 18.18%
  5. Copaxone: 2 people, 18.18%
  6. Prilosec: 1 person, 9.09%
  7. Prevacid: 1 person, 9.09%
  8. Pradaxa: 1 person, 9.09%
  9. Mayzent: 1 person, 9.09%
  10. Calcium Acetate: 1 person, 9.09%

Common symptoms for these people *:

  1. Gait Disturbance: 5 people, 45.45%
  2. Movement Disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness): 5 people, 45.45%
  3. Fall: 4 people, 36.36%
  4. Type 2 Diabetes: 4 people, 36.36%
  5. Pain In Extremity: 3 people, 27.27%
  6. Diabetes: 3 people, 27.27%
  7. Muscle Spasms (muscle contraction): 2 people, 18.18%
  8. Weight Decreased: 2 people, 18.18%
  9. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 18.18%
  10. Head Injury: 2 people, 18.18%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Nerve conduction studies abnormal?

- Check whether Nerve conduction studies abnormal is associated with a drug or a condition


Related publications that referenced our studies

Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Nerve conduction studies abnormal:

All the conditions that are associated with Nerve conduction studies abnormal:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Nerve conduction studies abnormal and Multiple sclerosis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: